Trademark: 85847199
Word
MYIMATINIB BECAUSE NO TWO PATIENTS ARE ALIKE
Status Date
Monday, April 28, 2014
Filing Date
Tuesday, February 12, 2013
Published for Opposition
Tuesday, July 30, 2013
Abandoned Date
Monday, April 28, 2014
42 Medical laboratory services; Medical laboratory services to determine the concentration of the drug imatinib mesylate in the blood of cancer patients
Color is not claimed as a feature of the mark.
"IMATINIB"
The mark consists of literal element "MYIMATINIB" positioned above the literal element "BECAUSE NO TWO PATIENTS ARE ALIKE". The letter "Y" is highly stylized in the form of a human figure with outstretched arms.
MY IMATINIB BECAUSE NO TWO PATIENTS ARE ALIKE
Apr 28, 2014
Abandonment Notice Mailed - No Use Statement Filed
Apr 28, 2014
Abandonment - No Use Statement Filed
Sep 24, 2013
Noa E-Mailed - Sou Required From Applicant
Jul 30, 2013
Official Gazette Publication Confirmation E-Mailed
Jul 30, 2013
Published For Opposition
Jul 10, 2013
Notification Of Notice Of Publication E-Mailed
Jun 22, 2013
Law Office Publication Review Completed
Jun 19, 2013
Assigned To Lie
Jun 4, 2013
Approved For Pub - Principal Register
Jun 4, 2013
Examiner's Amendment Entered
Jun 4, 2013
Notification Of Examiners Amendment E-Mailed
Jun 4, 2013
Examiners Amendment E-Mailed
Jun 4, 2013
Examiners Amendment -Written
May 28, 2013
Assigned To Examiner
Feb 20, 2013
Notice Of Design Search Code And Pseudo Mark E-Mailed
Feb 19, 2013
New Application Office Supplied Data Entered In Tram
Feb 15, 2013
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
